Motus GI files for $29M initial public offering — 3 insights

Motus GI Holdings, a medical device company, filed a $29 million initial public offering with the Securities Exchange Commission Jan. 5, Renaissance Capital reports.

Advertisement
By: Staff

Here’s what you should know:

1. Motus was founded in 2008. It plans to list on the Nasdaq under the symbol MOTS.

2. Piper Jaffray and Oppenheimer & Co. served as the joint bookrunners.

3. Motus initiated the filing on April 12, 2017.

More article on gastroenterology:
Top 10 states with the highest volume of gastroenterology procedures per ASC
GI leader to know: Dr. Christopher Brown of Atlanta Gastroenterology Associates
Northside Park Gastroenterology and Endoscopy Center owner Dr. Michael Sue to retire — 4 insights

Patient perception vs. reality: The role of accreditation in ASC safety

Recommended Whitepaper

Advertisement

Next Up in GI & Endoscopy

  • Providence opens new endoscopy center

    Renton, Wash.-based Providence has re-opened its North Coast Surgery Center in Oceanside, Calif., the Times Standard reported Feb. 5.  The…

    By: Francesca Mathewes

  • 5 moves disrupting the GI market

    Gastroenterology is rapidly transforming as health systems invest in outpatient digestive care, private equity-backed platforms expand and new technology reshapes…

    By: Sophie Eydis

  • Gastroenterology's AI revolution 

    AI’s early gains in gastroenterology are showing up in some of the most workflow-heavy parts of endoscopy — polyp detection,…

    By: Patsy Newitt
Advertisement

Comments are closed.